Literature DB >> 17207721

Elevated pulmonary artery pressure by Doppler echocardiography predicts hospitalization for heart failure and mortality in ambulatory stable coronary artery disease: the Heart and Soul Study.

Bryan Ristow1, Sadia Ali, Xiushui Ren, Mary A Whooley, Nelson B Schiller.   

Abstract

OBJECTIVES: We compared the predictive ability of tricuspid regurgitation (TR) and end-diastolic pulmonary regurgitation (EDPR) gradients in outpatients with coronary artery disease.
BACKGROUND: The TR and EDPR gradients, in conjunction with right atrial pressure, provide Doppler estimates of pulmonary artery systolic and diastolic pressures. We hypothesized that increases in TR or EDPR gradients in stable coronary artery disease would predict heart failure (HF) hospitalization or cardiovascular (CV) death.
METHODS: We measured TR and EDPR gradients in 717 adults with completed outcome adjudications who were recruited for the Heart and Soul Study. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for HF hospitalization, CV death, all-cause death, and the combined end point. Multivariate adjustments were made for age, gender, race, history of CV or pulmonary disease, functional class, and left ventricular ejection fraction.
RESULTS: There were 63 HF hospitalizations, 19 CV deaths, and 86 all-cause deaths at the 3-year follow-up. There were 466 measurable EDPR gradients and 573 measurable TR gradients. Age-adjusted ORs for EDPR >5 mm Hg predicted HF hospitalization (2.7, 95% CI 1.3 to 5.5, p = 0.006), all-cause death (2.5, 95% CI 1.4 to 4.4, p = 0.002), and HF hospitalization or CV death (2.7, 95% CI 1.4 to 5.2, p = 0.004). Age-adjusted OR for TR >30 mm Hg predicted HF hospitalization (3.4, 95% CI 1.9 to 6.2, p < 0.0001) and HF hospitalization or CV death (3.0, 95% CI 1.7 to 5.3, p = 0.0001). Multivariate adjusted OR per 5-mm Hg incremental increases in EDPR predicted HF hospitalization or CV death (1.9, 95% CI 1.01 to 3.6, p = 0.046) and all-cause death (1.7, 95% CI 1.05 to 2.8, p = 0.03). Multivariate adjusted OR per 10-mm Hg incremental increases in TR predicted HF hospitalization or CV death (1.6, 95% CI 1.1 to 2.4, p = 0.008).
CONCLUSIONS: Increases in EDPR or TR gradients predict HF hospitalization or CV death among ambulatory adults with coronary artery disease.

Entities:  

Mesh:

Year:  2006        PMID: 17207721      PMCID: PMC2771184          DOI: 10.1016/j.jacc.2006.04.108

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Echocardiographic determination of mean pulmonary artery pressure.

Authors:  Amr E Abbas; F David Fortuin; Nelson B Schiller; Christopher P Appleton; Carlos A Moreno; Steven J Lester
Journal:  Am J Cardiol       Date:  2003-12-01       Impact factor: 2.778

2.  Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications.

Authors:  Joseph F Malouf; Maurice Enriquez-Sarano; Patricia A Pellikka; Jae K Oh; Kent R Bailey; Krishnaswamy Chandrasekaran; Charles J Mullany; A Jamil Tajik
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

3.  Noninvasive evaluation of intracardiac pressures using Doppler ultrasound: a case study of panvalvular regurgitation.

Authors:  P G Yock; R L Popp
Journal:  Clin Cardiol       Date:  1985-11       Impact factor: 2.882

4.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

5.  Scleroderma patients with combined pulmonary hypertension and interstitial lung disease.

Authors:  Betty Chang; Fredrick M Wigley; Barbara White; Robert A Wise
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

6.  Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy.

Authors:  Pinming Liu; Nicolas Meneveau; François Schiele; Jean-Pierre Bassan
Journal:  Chin Med J (Engl)       Date:  2003-04       Impact factor: 2.628

7.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  A simple method for noninvasive estimation of pulmonary vascular resistance.

Authors:  Amr E Abbas; F David Fortuin; Nelson B Schiller; Christopher P Appleton; Carlos A Moreno; Steven J Lester
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

9.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

10.  Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure.

Authors:  T Masuyama; K Kodama; A Kitabatake; H Sato; S Nanto; M Inoue
Journal:  Circulation       Date:  1986-09       Impact factor: 29.690

View more
  18 in total

Review 1.  Phase II trials in heart failure: the role of cardiovascular imaging.

Authors:  Sanjiv J Shah; Gregg C Fonarow; Mihai Gheorghiade; Roberto M Lang
Journal:  Am Heart J       Date:  2011-07       Impact factor: 4.749

2.  Elevated pulmonary artery systolic pressure predicts heart failure admissions in African Americans: Jackson Heart Study.

Authors:  Gaurav Choudhary; Matthew Jankowich; Wen-Chih Wu
Journal:  Circ Heart Fail       Date:  2014-06-05       Impact factor: 8.790

3.  A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model.

Authors:  Juha W Koskenvuo; Rachel Mirsky; Yan Zhang; Franca S Angeli; Sarah Jahn; Tero-Pekka Alastalo; Nelson B Schiller; Andrew J Boyle; Kanu Chatterjee; Teresa De Marco; Yerem Yeghiazarians
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-07       Impact factor: 2.357

4.  Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study.

Authors:  Steven M Stevens; Ramin Farzaneh-Far; Beeya Na; Mary A Whooley; Nelson B Schiller
Journal:  JACC Cardiovasc Imaging       Date:  2009-01

Review 5.  Symptom perception in CHF: (why mind matters).

Authors:  Christine E Skotzko
Journal:  Heart Fail Rev       Date:  2007-12-11       Impact factor: 4.214

6.  A simple echocardiographic method to estimate pulmonary vascular resistance.

Authors:  Alexander R Opotowsky; Mathieu Clair; Jonathan Afilalo; Michael J Landzberg; Aaron B Waxman; Lilamarie Moko; Bradley A Maron; Anjali Vaidya; Paul R Forfia
Journal:  Am J Cardiol       Date:  2013-06-01       Impact factor: 2.778

Review 7.  Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Barry A Borlaug; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

8.  Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study.

Authors:  Kiran K Khush; Sanjiv J Shah; Bryan Ristow; Teresa De Marco; Mary A Whooley; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2007-06-25       Impact factor: 5.251

9.  Association of Machine Learning-Derived Phenogroupings of Echocardiographic Variables with Heart Failure in Stable Coronary Artery Disease: The Heart and Soul Study.

Authors:  Rakesh K Mishra; Geoffrey H Tison; Qizhi Fang; Rebecca Scherzer; Mary A Whooley; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2020-01-14       Impact factor: 5.251

10.  Usefulness of noninvasive estimate of pulmonary vascular resistance to predict mortality, heart failure, and adverse cardiovascular events in Patients With stable coronary artery disease (from the Heart and Soul Study).

Authors:  Ramin Farzaneh-Far; Beeya Na; Mary A Whooley; Nelson B Schiller
Journal:  Am J Cardiol       Date:  2008-02-21       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.